* Catalyst Pharmaceuticals announces FDA orphan drug
designation of Firdapse for the treatment of Myasthenia Gravis
The post BRIEF-Catalyst Pharmaceuticals announces FDA orphan drug designation of Firdapse appeared first on NASDAQ.
BRIEF-Catalyst Pharmaceuticals announces FDA orphan drug designation of Firdapse
